Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Mail to Mr. West (analyst from Dutton)

You would think they would mention that PTSC is waiting on a crucial USPTO re-exam (that could go either way) rather than stating we see know reason why the royalty payments should cease.

I wish I knew what they know or what I'm missing LOL!

Share
New Message
Please login to post a reply